Charles A. Tharp

Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling

T. McKinsey, E. Seto, J. Cao, 2022, Proceedings of the National Academy of Sciences.

Modifications of Titin Contribute to the Progression of Cardiomyopathy and Represent a Therapeutic Target for Treatment of Heart Failure

L. Mestroni, Matthew R. G. Taylor, Charles A. Tharp, 2020, Journal of clinical medicine.

The Sarcomeric Spring Protein Titin: Biophysical Properties, Molecular Mechanisms, and Genetic Mutations Associated with Heart Failure and Cardiomyopathy

L. Mestroni, O. Sbaizero, Matthew R. G. Taylor, 2021, Current Cardiology Reports.

The Giant Protein Titin’s Role in Cardiomyopathy: Genetic, Transcriptional, and Post-translational Modifications of TTN and Their Contribution to Cardiac Disease

L. Mestroni, O. Sbaizero, Matthew R. G. Taylor, 2019, Front. Physiol..

FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy

Kenneth L. Jones, L. Mestroni, Matthew R. G. Taylor, 2016, JACC. Basic to translational science.

Therapeutic targets for cardiac fibrosis: from old school to next-gen

T. McKinsey, M. Rubino, Charles A. Tharp, 2022, The Journal of clinical investigation.

Abstract 11923: FLNC Gene Splice Mutation Causes Dilated Cardiomyopathy in Two Families

Kenneth L. Jones, L. Mestroni, Matthew R. G. Taylor, 2014 .

Molecular genetics of dilated cardiomyopathy.

L. Mestroni, M. Giacca, S. Graw, 2014, Current opinion in cardiology.